# EDGAR Filing Document

**Accession Number:** 0001016835
**File Stem:** 0000950170-25-084319
**Filing Date:** 2025-6
**Character Count:** 13964
**Document Hash:** be76c59ef9950d4265eebf8e0a1f0047
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0000950170-25-084319.hdr.sgml**: 20250610

**ACCESSION NUMBER**: 0000950170-25-084319

**CONFORMED SUBMISSION TYPE**: SCHEDULE 13D/A

**PUBLIC DOCUMENT COUNT**: 1

**FILED AS OF DATE**: 20250610

**DATE AS OF CHANGE**: 20250610

**SUBJECT COMPANY**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** Cibus, Inc.
- **CENTRAL INDEX KEY:** 0001705843
- **STANDARD INDUSTRIAL CLASSIFICATION:** AGRICULTURE CHEMICALS [2870]
- **ORGANIZATION NAME:** 08 Industrial Applications and Services
- **EIN:** 271967997
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** SCHEDULE 13D/A
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 005-90065
- **FILM NUMBER:** 251037259

**BUSINESS ADDRESS:**
- **STREET 1:** 6455 NANCY RIDGE DRIVE
- **CITY:** SAN DIEGO
- **STATE:** CA
- **ZIP:** 92121
- **BUSINESS PHONE:** (858) 450-0008

**MAIL ADDRESS:**
- **STREET 1:** 6455 NANCY RIDGE DRIVE
- **CITY:** SAN DIEGO
- **STATE:** CA
- **ZIP:** 92121

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** Calyxt, Inc.
- **DATE OF NAME CHANGE:** 20170504
**FILED BY**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** RIGGS RORY B
- **CENTRAL INDEX KEY:** 0001016835

**ORGANIZATION NAME:**

**FILING VALUES:**
- **FORM TYPE:** SCHEDULE 13D/A

**MAIL ADDRESS:**
- **STREET 1:** 65 RAILROAD AVE
- **CITY:** RIDGEFIELD
- **STATE:** NJ
- **ZIP:** 07657

### UNITED STATES SECURITIES AND EXCHANGE COMMISSION
**Washington, D.C. 20549**

## SCHEDULE 13D

### Under the Securities Exchange Act of 1934

**(Amendment No. 1)**

**Cibus, Inc.**

*(Name of Issuer)*

**Class A Common Stock, $0.0001 par value per share**

*(Title of Class of Securities)*

**17166A101**

*(CUSIP Number)*

**Rory B. Riggs**<br>c/o Cibus, Inc.<br>6455 Nancy Ridge Drive<br>San Diego CA 92121<br>1-858-450-0008

*(Name, Address and Telephone Number of Person Authorized to Receive Notices and Communications)*

**09/18/2024**

*(Date of Event Which Requires Filing of this Statement)*

| **CUSIP No.** | **17166A101** |

---

| | | | |
|:--|:--|:--|:--|
| 1 | Name of reporting person<br>**Rory B. Riggs** | Name of reporting person<br>**Rory B. Riggs** | |
| 2 | Check the appropriate box if a member of a Group (See Instructions)<br>[x] (a)<br>[ ] (b) | Check the appropriate box if a member of a Group (See Instructions)<br>[x] (a)<br>[ ] (b) | |
| 3 | SEC use only | SEC use only | |
| 4 | Source of funds (See Instructions)<br>**PF** | Source of funds (See Instructions)<br>**PF** | |
| 5 | Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)<br>[ ] | Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)<br>[ ] | |
| 6 | Citizenship or place of organization<br>**X1** | Citizenship or place of organization<br>**X1** | |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 7 | Sole Voting Power<br>**18699753.00** |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 8 | Shared Voting Power<br>**26375.00** |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 9 | Sole Dispositive Power<br>**18699753.00** |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 10 | Shared Dispositive Power<br>**26375.00** |
| 11 | Aggregate amount beneficially owned by each reporting person<br>**18726128.00** | Aggregate amount beneficially owned by each reporting person<br>**18726128.00** | |
| 12 | Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)<br>[ ] | Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)<br>[ ] | |
| 13 | Percent of class represented by amount in Row (11)<br>**33.02%** | Percent of class represented by amount in Row (11)<br>**33.02%** | |
| 14 | Type of Reporting Person (See Instructions)<br>**IN** | Type of Reporting Person (See Instructions)<br>**IN** | |

---

**Comment for Reporting Person:** The amounts in rows 7 and 9 represent (i) 14,530,385 shares of Class A common stock, par value $0.0001 per share ("Class A Common Stock"), inclusive of 4,050,000 shares of Class A Common Stock issuable in connection with the Reporting Person's 2023 Pre-Funded Warrants and 2025 Pre-Funded Warrants, (ii) 47,521 shares of restricted Class A Common Stock issued pursuant to the Cibus, Inc. 2017 Omnibus Incentive Plan, subject to vesting, (iii) 23,807 shares of Class A Common Stock held indirectly through the Rory Riggs Family Trust, and (iv) a maximum of 4,098,040 shares issuable upon the exercise of common warrants with an exercise price of $2.50 per share (the "2024 Common Warrants") and/or common warrants with an exercise price of $2.50 per share (the "2025 Common Warrants").

The amounts in rows 8 and 10 in the table above represent (i) 5,401 shares of Class A Common Stock jointly held by Mr. Riggs and a sibling and (ii) 20,974 shares of Class A Common Stock held of record by Mr. Riggs' spouse, for which Mr. Riggs shares voting and investment power.

The percentage presented in row 13 above is calculated based on total outstanding shares of Class A Common Stock of Cibus, Inc. (the "Issuer") of 56,712,351, which reflects the sum of (v) 32,672,181 shares of Class A Common Stock outstanding as of May 7, 2025 (w) 177,845 restricted shares of Class A Common Stock of the Issuer outstanding as of May 7, 2025, which remain subject to vesting, (x) 4,050,000 shares of Class A Common Stock issuable by the Issuer in connection with the Reporting Person's 2023 Pre-Funded Warrants and 2025 Pre-Funded Warrants, (y) 15,714,285 shares issued by the Issuer in its public offering, and (z) 4,098,040 shares of Class A Common Stock issuable upon the exercise of the 2024 Common Warrants and/or the 2025 Common Warrants, in each case as provided to the Reporting Person by the Issuer.

**Item 1. Security and Issuer**

**(a) Title of Class of Securities:**
Class A Common Stock, $0.0001 par value per share

**(b) Name of Issuer:**
Cibus, Inc.

**(c) Address of Issuer's Principal Executive Offices:**
6455 Nancy Ridge Drive, San Diego, CA, 92121

This Amendment No. 1 to the statement of beneficial ownership on Schedule 13D (this "Amendment No. 1") amends the Schedule 13D originally filed by Rory B. Riggs (the "Reporting Person") with the United States Securities Exchange Commission (the "SEC") on June 12, 2023 (the "Initial Schedule 13D" and, as amended by this Amendment No. 1, the "Schedule 13D"), relating to shares of Class A Common Stock of the Issuer.

**Item 4. Purpose of Transaction**

Item 4 of the Initial Schedule 13D is amended and restated in its entirety as follows:

The Reporting Person was appointed as Chair of the board of directors of the Issuer in connection with the Issuer's merger with Cibus Global, LLC on May 31, 2023. Previously, Mr. Riggs served as the Issuer's Chief Executive Officer from May 31, 2023 through February 24, 2025. As Chair of the board of directors and the Issuer's largest stockholder, the Reporting Person has significant influence over the corporate activities of the Issuer, including activities which may relate to items described in subparagraphs (a) through (j) of Item 4 of Schedule 13D.

The Reporting Person holds shares of Class A Common Stock, 2024 Common Warrants and 2025 Common Warrants.  The Reporting Person presently considers the foregoing securities as an investment and intends to review such investment on an ongoing basis, taking into account a number of factors, including, without limitation, general market and economic conditions. In connection with each of the December 2023 Registered Direct, the June 2024 Registered Direct, the September 2024 Public Offering, the January 2025 Registered Direct and the June 2025 Public Offering, the Reporting Person agreed to be subject to a lock-up agreement described in Item 6 of Amendment No. 1.  Any purchases or sales made by the Reporting Person will be subject to the Issuer's Insider Trading Policy for so long as the Reporting Person remains subject thereto.

From time to time, the Reporting Person may exercise the 2024 Common Warrants and/or the 2025 Common Warrants.

**Item 5. Interest in Securities of the Issuer**

**(a)**
Item 5(a) of the Initial Schedule 13D is amended as follows:  As of the date hereof, the Reporting Person beneficially owns 18,726,128 shares of Class A Common Stock, representing approximately 33.02% of the outstanding shares of Class A Common Stock of the Issuer.  See the cover page of Amendment No. 1 for additional information.

**(b)**
Item 5(b) of the Initial Schedule 13D is amended as follows:  As of the date hereof, the Reporting Person beneficially owns 18,699,753 shares of Class A Common Stock over which the Reporting Person has sole voting and disposition power and 26,375 shares of Class A Common Stock over which the Reporting Person has shared voting and disposition power.  See the cover page of Amendment No. 1 for additional information.

**(c)**
Item 5(c) of the Initial Schedule 13D is amended as follows: Except as disclosed in this Amendment No. 1 with respect to the Reporting Person's purchase in the June 2025 Public Offering and the Reporting Person's exercise of the 2023 Pre-Funded Warrants and the 2025 Pre-Funded Warrants, the Reporting Person has not effected any transactions in the shares of Class A Common Stock in the past 60 days.

**Item 6. Contracts, Arrangements, Understandings or Relationships With Respect to Securities of the Issuer.**

Item 6 of the Schedule 13D is hereby amended and supplemented as follows:

Lock-Up Agreements

In connection with each of the December 2023 Registered Direct, the June 2024 Registered Direct, the September 2024 Public Offering, the January 2025 Registered Direct and the June 2025 Public Offering, the Reporting Person entered into a lock-up agreement, pursuant to which the Reporting Person agreed, subject to specified exceptions, not to sell or transfer any shares of Class A Common Stock or securities convertible into, or exchangeable or exercisable for, shares of Class A Common Stock during a specified period of 90 days, 60 days, 30 days, 60 days and 60 days, respectively.  Notwithstanding these limitations, the lock-up agreements permitted shares of Class A Common Stock to be transferred under limited circumstances, including, without limitation, by gift, will or intestate succession and in connection with the satisfaction of certain tax obligations.

The foregoing description of the lock-up agreements is not complete and is qualified in its entirety by the full text of the lock-up agreements attached as Exhibits 1.10, 1.11, 1.12, 1.13 and 1.14 to Amendment No. 1, each incorporated herein by reference.

Registration Rights Agreement, As Amended

On May 31, 2023, the Issuer entered into a Registration Rights Agreement (the "Registration Rights Agreement") with the Electing Members in connection with the Transactions. The Registration Rights Agreement provides the Electing Members certain registration rights whereby, at any time following the consummation of the Transactions and the expiration of any related lock-up period, the Electing Members can require the Issuer to register under the Securities Act of 1933, as amended, shares of Class A Common Stock issuable to them upon exchange of the Up-C Units.

On December 27, 2023, the Company and a Cibus Global Majority-in-Interest (as defined in the Registration Rights Agreement) entered into the First Amendment to the Registration Rights Agreement (the "First Amendment"). The First Amendment amended the Registration Rights Agreement to clarify that at any time in which the Shelf Registration Statement required pursuant to Section 2(c)(i) is effective, "piggyback" registration rights shall be inapplicable in respect of any primary Registration of offering thereunder of securities by the Issuer

The foregoing description of the Registration Rights Agreement is not complete and is qualified in its entirety by the full text of the Registration Rights Agreement attached as Exhibit 1.05 to the Schedule 13D, as amended by the First Amendment to the Registration Rights Agreement attached as Exhibit 1.05.1 to the Schedule 13D, each incorporated herein by reference.

Warrant Amendment Agreement

Certain investors in the January 2025 Registered Direct were holders of 2024 Common Warrants (collectively, the "Investor Warrants"). The exercise price for the Investor Warrants initially was $10.00 per share, except that the exercise price of the Investor Warrants issued to Mr. Riggs initially was $10.07 per share. Concurrent with the 2025 Registered Direct, the Company agreed to contractual amendments (the "Warrant Amendment Agreement") to (i) reduce the exercise price of the Investor Warrants to $2.50 per share, (ii) reduce the threshold for satisfaction of the Trading Condition (as defined in the Investor Warrants) in respect of the redemption provisions to $5.00 per share, and (iii) extend the termination date of the Investor Warrants to five years following the closing of the January 2025 Registered Direct, effective upon the consummation of the 2025 Registered Direct. The Warrant Amendment Agreement, with respect to Investor Warrants held by the Reporting Person, was conditioned on, and would not be effective until, the trading day after the Company obtained the requisite approval from its stockholders with respect to the Investor Warrants held by the Reporting Person. On May 22, 2025, the Company's stockholders approved the Warrant Amendment Agreement with respect to the Investor Warrants held by the Reporting Person.

### SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

**Reporting Person:** Rory B. Riggs

**Signature:** /s/ Rory B. Riggs

**Name/Title:** Rory B. Riggs

**Date:** 06/10/2025